Back to results
US 2024/0254513 A1Published application
Viral vector production systems, engineered cells for viral vector production, and methods of use thereof
AssigneeAsimov Inc.
InventorsJeremy J. Gam, Christopher S. Stach, Alec A.K. Nielsen
Life of this patent
Estimating the term…
Abstract
Described herein are viral vector production systems and engineered cells for viral vector production. Also described herein are methods of using the engineered cells to produce viral vectors.
Claims82
A viral vector production system comprising:
- (a) an engineered cell comprising a viral vector production component comprising one or more heterologous polynucleic acids that collectively encode the gene products of a viral vector;
- (b) a heterologous nucleic acid sequence encoding for a first expression cassette, wherein the first expression cassette comprises a nucleic acid sequence of a constitutive promoter operably linked to a nucleic acid sequence encoding a regulatory RNA;
- and
- (c) a transfer polynucleic acid comprising a central nucleic acid sequence flanked, on the 5′ and 3′ end, by a nucleic acid sequence of a viral terminal repeat.
1 more element
An engineered cell for viral vector production comprising one or more heterologous polynucleic acids collectively comprising:
- (a) a viral vector production component collectively encoding the gene products of a viral vector;
- (b) a first expression cassette, wherein the first expression cassette comprises a nucleic acid sequence of a constitutive promoter operably linked to a nucleic acid sequence encoding an shRNA or amiRNA;
- and
- (c) a transfer polynucleic acid comprising a central nucleic acid sequence flanked, on the 5′ and 3′ end, by a nucleic acid sequence of a viral terminal repeat, wherein the central nucleic acid sequence comprises a nucleic acid sequence encoding a payload molecule operably linked to both a promoter and a target nucleic acid sequence that complements the shRNA or amiRNA encoded by the first expression cassette.
1 more element
An engineered cell for viral vector production comprising one or more heterologous polynucleic acids collectively comprising:
- (a) a viral vector production component collectively encoding the gene products of a viral vector;
- (b) a first expression cassette, wherein the first expression cassette comprises a nucleic acid sequence of a constitutive promoter operably linked to a nucleic acid sequence encoding a Cas13 guide RNA;
- (c) a nucleic acid sequence encoding Cas13;
- and
- (d) a transfer polynucleic acid comprising a central nucleic acid sequence flanked, on the 5′ and 3′ end, by a nucleic acid sequence of a viral terminal repeat, wherein the central nucleic acid sequence comprises a nucleic acid sequence encoding a payload molecule operably linked to both a promoter and a target nucleic acid sequence that complements the Cas13 guide RNA encoded by the first expression cassette.
2 more elements
Dependencies are inferred from the claim text.